{"doc_id": "33082342", "type of study": "Therapy", "title": "", "abstract": "A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics.\nHere, we randomized 53 patients hospitalized with coronavirus disease 2019 (COVID-19) to hydroxychloroquine therapy (at a dose of 400\u2009mg twice daily for seven days) in addition to standard care or standard care alone (ClinicalTrials.gov Identifier, NCT04316377).\nAll severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive patients 18 years of age or older were eligible for study inclusion if they had moderately severe COVID-19 at admission.\nTreatment with hydroxychloroquine did not result in a significantly greater rate of decline in SARS-CoV-2 oropharyngeal viral load compared to standard care alone during the first five days.\nOur results suggest no important antiviral effect of hydroxychloroquine in humans infected with SARS-CoV-2.\n", "Evidence Map": {"Enrollment": [{"term": "hospitalized", "negation": "affirmed", "UMLS": {}, "start": 33, "end": 45}, {"term": "coronavirus disease 2019 ( COVID-19 )", "negation": "affirmed", "UMLS": {}, "start": 51, "end": 88}, {"term": "severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) positive", "negation": "affirmed", "UMLS": {}, "start": 4, "end": 75}, {"term": "moderately severe COVID-19", "negation": "affirmed", "UMLS": {}, "start": 156, "end": 182}, {"term": "SARS-CoV-2", "negation": "negated", "UMLS": {}, "start": 96, "end": 106}], "Comparison Results": [], "Study Arm 1 Results": [], "Study Arm 2 Results": [], "Hypothesis": []}, "Sentence-level breakdown": [{"Section": "TITLE", "Text": "A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "hydroxychloroquine", "negation": "negated", "UMLS": {}, "start": 68, "end": 86}], "Outcome": [{"term": "coronavirus disease 2019 viral kinetics", "negation": "negated", "UMLS": {}, "start": 90, "end": 129}], "Observation": [{"term": "lack", "negation": "affirmed", "UMLS": {}, "start": 48, "end": 52}, {"term": "efficacy", "negation": "negated", "UMLS": {}, "start": 56, "end": 64}], "Count": []}, "Evidence Propositions": [{"Intervention": "hydroxychloroquine", "Observation": "lack", "Outcome": "coronavirus disease 2019 viral kinetics", "Count": ""}, {"Intervention": "hydroxychloroquine", "Observation": "efficacy", "Outcome": "coronavirus disease 2019 viral kinetics", "Count": ""}]}, {"Section": "UNKNOWN", "Text": "Here , we randomized 53 patients hospitalized with coronavirus disease 2019 ( COVID-19 ) to hydroxychloroquine therapy ( at a dose of 400 mg twice daily for seven days ) in addition to standard care or standard care alone ( ClinicalTrials.gov Identifier , NCT04316377 ) .", "Evidence Elements": {"Participant": [{"term": "hospitalized", "negation": "affirmed", "UMLS": {}, "start": 33, "end": 45}, {"term": "coronavirus disease 2019 ( COVID-19 )", "negation": "affirmed", "UMLS": {}, "start": 51, "end": 88}], "Intervention": [{"term": "hydroxychloroquine therapy", "negation": "affirmed", "UMLS": {}, "start": 92, "end": 118}, {"term": "in addition to", "negation": "affirmed", "UMLS": {}, "start": 170, "end": 184}, {"term": "standard care", "negation": "affirmed", "UMLS": {}, "start": 185, "end": 198}, {"term": "standard", "negation": "affirmed", "UMLS": {}, "start": 185, "end": 193}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "All severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) positive patients 18 years of age or older were eligible for study inclusion if they had moderately severe COVID-19 at admission .", "Evidence Elements": {"Participant": [{"term": "severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) positive", "negation": "affirmed", "UMLS": {}, "start": 4, "end": 75}, {"term": "moderately severe COVID-19", "negation": "affirmed", "UMLS": {}, "start": 156, "end": 182}], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Treatment with hydroxychloroquine did not result in a significantly greater rate of decline in SARS-CoV-2 oropharyngeal viral load compared to standard care alone during the first five days .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "hydroxychloroquine", "negation": "affirmed", "UMLS": {}, "start": 15, "end": 33}, {"term": "standard care alone", "negation": "negated", "UMLS": {}, "start": 143, "end": 162}], "Outcome": [{"term": "rate of decline in SARS-CoV-2 oropharyngeal viral load", "negation": "negated", "UMLS": {}, "start": 76, "end": 130}], "Observation": [{"term": "significantly greater", "negation": "negated", "UMLS": {}, "start": 54, "end": 75}], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Our results suggest no important antiviral effect of hydroxychloroquine in humans infected with SARS-CoV-2 .", "Evidence Elements": {"Participant": [{"term": "SARS-CoV-2", "negation": "negated", "UMLS": {}, "start": 96, "end": 106}], "Intervention": [{"term": "hydroxychloroquine", "negation": "negated", "UMLS": {}, "start": 53, "end": 71}], "Outcome": [{"term": "antiviral effect", "negation": "negated", "UMLS": {}, "start": 33, "end": 49}], "Observation": [{"term": "important", "negation": "negated", "UMLS": {}, "start": 23, "end": 32}], "Count": []}, "Evidence Propositions": []}]}